These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29563072)

  • 1. d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study.
    Pradhan B; Mitrev L; Moaddell R; Wainer IW
    Biochim Biophys Acta Proteins Proteom; 2018 Jul; 1866(7):831-839. PubMed ID: 29563072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.
    Moaddel R; Luckenbaugh DA; Xie Y; Villaseñor A; Brutsche NE; Machado-Vieira R; Ramamoorthy A; Lorenzo MP; Garcia A; Bernier M; Torjman MC; Barbas C; Zarate CA; Wainer IW
    Psychopharmacology (Berl); 2015 Jan; 232(2):399-409. PubMed ID: 25056852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonconventional interventions for chronic post-traumatic stress disorder: Ketamine, repetitive trans-cranial magnetic stimulation (rTMS), and alternative approaches.
    Pradhan B; Kluewer D'Amico J; Makani R; Parikh T
    J Trauma Dissociation; 2016; 17(1):35-54. PubMed ID: 26162001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder.
    Heresco-Levy U; Vass A; Bloch B; Wolosker H; Dumin E; Balan L; Deutsch L; Kremer I
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1275-82. PubMed ID: 19366490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Ketamine, Brain Stimulation (rTMS) and Mindfulness Therapy (TIMBER) for Opioid Addiction.
    Pradhan B; Rossi G
    Cureus; 2020 Nov; 12(11):e11798. PubMed ID: 33409043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
    Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS
    JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder.
    Fortuna LR; Porche MV; Padilla A
    Psychol Psychother; 2018 Mar; 91(1):42-62. PubMed ID: 28815876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term structural and functional neural changes following a single infusion of Ketamine in PTSD.
    Duek O; Korem N; Li Y; Kelmendi B; Amen S; Gordon C; Milne M; Krystal JH; Levy I; Harpaz-Rotem I
    Neuropsychopharmacology; 2023 Oct; 48(11):1648-1658. PubMed ID: 37270621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
    Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
    Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of group mindfulness-based cognitive therapy (MBCT) for combat veterans with posttraumatic stress disorder (PTSD).
    King AP; Erickson TM; Giardino ND; Favorite T; Rauch SA; Robinson E; Kulkarni M; Liberzon I
    Depress Anxiety; 2013 Jul; 30(7):638-45. PubMed ID: 23596092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-deployment programmes for building resilience in military and frontline emergency service personnel.
    Doody CB; Robertson L; Cox KM; Bogue J; Egan J; Sarma KM
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013242. PubMed ID: 34870330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing meditative scuba diving versus multisport activities to improve post-traumatic stress disorder symptoms: a pilot, randomized controlled clinical trial.
    Gibert L; Coulange M; Reynier JC; Le Quiniat F; Molle A; Bénéton F; Meurice V; Micoulaud JA; Trousselard M
    Eur J Psychotraumatol; 2022; 13(1):2031590. PubMed ID: 35145610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of ketamine as a novel treatment for posttraumatic stress disorder.
    Feder A; Rutter SB; Schiller D; Charney DS
    Adv Pharmacol; 2020; 89():261-286. PubMed ID: 32616209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Treatment of Neurocognitive and Psychiatric Symptoms in Veterans with Post-Traumatic Stress Disorder and History of Mild Traumatic Brain Injury: A Pilot Study of Mindfulness-Based Stress Reduction.
    Cole MA; Muir JJ; Gans JJ; Shin LM; D'Esposito M; Harel BT; Schembri A
    Mil Med; 2015 Sep; 180(9):956-63. PubMed ID: 26327547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
    Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
    Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindfulness-Based Stress Reduction for Posttraumatic Stress Disorder Among Veterans: A Randomized Clinical Trial.
    Polusny MA; Erbes CR; Thuras P; Moran A; Lamberty GJ; Collins RC; Rodman JL; Lim KO
    JAMA; 2015 Aug; 314(5):456-65. PubMed ID: 26241597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal blood DHEA-S/cortisol levels predicts EMDR treatment response in adolescents with PTSD.
    Usta MB; Gumus YY; Say GN; Bozkurt A; Şahin B; Karabekiroğlu K
    Nord J Psychiatry; 2018 Apr; 72(3):164-172. PubMed ID: 29171317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of adjuvant mindfulness-based cognitive therapy (MBCT) on symptoms of post-traumatic stress disorder (PTSD) in veterans - results from a randomized control study.
    Jasbi M; Sadeghi Bahmani D; Karami G; Omidbeygi M; Peyravi M; Panahi A; Mirzaee J; Holsboer-Trachsler E; Brand S
    Cogn Behav Ther; 2018 Sep; 47(5):431-446. PubMed ID: 29893182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
    Abdallah CG; Roache JD; Gueorguieva R; Averill LA; Young-McCaughan S; Shiroma PR; Purohit P; Brundige A; Murff W; Ahn KH; Sherif MA; Baltutis EJ; Ranganathan M; D'Souza D; Martini B; Southwick SM; Petrakis IL; Burson RR; Guthmiller KB; López-Roca AL; Lautenschlager KA; McCallin JP; Hoch MB; Timchenko A; Souza SE; Bryant CE; Mintz J; Litz BT; Williamson DE; Keane TM; Peterson AL; Krystal JH
    Neuropsychopharmacology; 2022 Jul; 47(8):1574-1581. PubMed ID: 35046508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of ketamine NMDA receptor blocker as a therapeutic intervention for PTSD review of a randomized clinical trial.
    Jumaili WA; Trivedi C; Chao T; Kubosumi A; Jain S
    Behav Brain Res; 2022 Apr; 424():113804. PubMed ID: 35181391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.